Literature DB >> 34179149

Commentary: Vasodilator Myocardial Perfusion Cardiac Magnetic Resonance Imaging Is Superior to Dobutamine Stress Echocardiography in the Detection of Relevant Coronary Artery Stenosis: A Systematic Review and Meta-Analysis on Their Diagnostic Accuracy.

Attila Kardos1,2, Roxy Senior3, Harald Becher4.   

Abstract

Entities:  

Keywords:  cardiac MRI; chronic coronary syndrome; diagnostic accuracy and yield; discussion points; stress echocardiography

Year:  2021        PMID: 34179149      PMCID: PMC8222596          DOI: 10.3389/fcvm.2021.694323

Source DB:  PubMed          Journal:  Front Cardiovasc Med        ISSN: 2297-055X


× No keyword cloud information.
We are grateful to the authors for sharing the results of this very precise and detailed analysis of comparing the diagnostic performance of perfusion cardiac magnetic resonance (pCMR) and dobutamine stress echocardiography (DSE) for the detection of coronary artery stenosis with the scientific readership as the two functional test modalities without associated harmful radiation (1). The authors found higher sensitivity for pCMR vs. DSE (0.88 vs. 0.720) with a negative likelihood ratio of 0.14 vs. 0.31, respectively. There was no difference in specificity. We acknowledge the precise nature of the work. However, we would like to raise some points that may be worthwhile considering. (1) This meta-analysis takes historical studies into account using either DSE or pCMR that compared the functional test results to that of invasive or coronary CT angiography (CCTA) or invasive fractional flow reserve. Albeit these are the only data available for comparison, it may question the legitimacy of comparing two functional tests with different principles to address coronary artery disease (CAD) severity detection. With this in mind, one would look for studies that are comparing the effect of the same stressor (e.g., coronary vasodilators) that investigates the accuracy of the imaging modality, i.e., echocardiography vs. CMR in detecting inducible ischemia and significant CAD. One such methodological comparison was showing no difference in the accuracy between echocardiography vs. CMR using vasodilator stress test in the same patients' cohort (2). (2) The majority of the included DSE studies were performed before 2000 without using ultrasound-enhancing contrast agents (UECAs). Not until 2009, the European Association of Cardiovascular Imaging recommended UECA to be used regularly during echocardiography where >2 segments of the left ventricle are not delineated properly (3). This certainly was a major step forward in improving interpretability and increasing operator confidence during stress echocardiography. However, recent comparisons of contrast-enhanced stress echocardiography with coronary angiography mainly used vasodilator stress test. Further randomized, prospective studies with contemporary imaging techniques and modalities, e.g., contrast-enhanced stress echocardiography, may help our understanding of the strength and weaknesses of those modalities. (3) Although the diagnostic accuracy is essential, the prediction of outcome and/or risk stratification following a test is probably more important. In this respect, both pCMR (4–6) and DSE (7–9) have robust data, although with no head-to-head comparative studies. Stress echocardiography has consistently shown that a normal study identifies a low-risk cohort who needs no further testing, while significant ischemia identifies a high-risk group. In addition, the Mayo Clinic group has shown the same outcome in patients with abnormal stress echo findings regardless of the degree of coronary artery stenosis by Invasive Coronary Angiography (10). This meta-analysis did not evaluate outcome prediction nor risk stratification. (4) Thus, current European Society of Cardiology and American Heart Association guidelines for chest pain assessment in chronic coronary syndrome patients with intermediate pretest probability recommend a non-invasive functional test [stress echocardiography, single-photon emission computed tomography, CMR] as well as an anatomical test, such as CCTA as the initial test, guided by the local expertise and infrastructure (11). In order to recommend CMR as a first-line diagnostic test, further comparative studies on risk stratification, management-based outcome, and cost-effectiveness need to be demonstrated.

Author Contributions

All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  11 in total

Review 1.  Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography.

Authors:  Roxy Senior; Harald Becher; Mark Monaghan; Luciano Agati; Jose Zamorano; Jean Louis Vanoverschelde; Petros Nihoyannopoulos
Journal:  Eur J Echocardiogr       Date:  2009-03

2.  Prediction of mortality by stress echocardiography in 2835 diabetic and 11 305 nondiabetic patients.

Authors:  Lauro Cortigiani; Lucia Borelli; Mauro Raciti; Francesco Bovenzi; Eugenio Picano; Sabrina Molinaro; Rosa Sicari
Journal:  Circ Cardiovasc Imaging       Date:  2015-05       Impact factor: 7.792

3.  Prognostic Value of Vasodilator Stress Cardiac Magnetic Resonance Imaging: A Multicenter Study With 48 000 Patient-Years of Follow-up.

Authors:  John F Heitner; Raymond J Kim; Han W Kim; Igor Klem; Dipan J Shah; Dany Debs; Afshin Farzaneh-Far; Venkateshwar Polsani; Jiwon Kim; Jonathan Weinsaft; Chetan Shenoy; Andrew Hughes; Preston Cargile; Jean Ho; Robert O Bonow; Elizabeth Jenista; Michele Parker; Robert M Judd
Journal:  JAMA Cardiol       Date:  2019-03-01       Impact factor: 14.676

4.  Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease.

Authors:  Thomas H Marwick; Colin Case; Stephen Sawada; Charles Vasey; Leanne Short; Michael Lauer
Journal:  Diabetes Care       Date:  2002-06       Impact factor: 19.112

5.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Authors:  Juhani Knuuti; William Wijns; Antti Saraste; Davide Capodanno; Emanuele Barbato; Christian Funck-Brentano; Eva Prescott; Robert F Storey; Christi Deaton; Thomas Cuisset; Stefan Agewall; Kenneth Dickstein; Thor Edvardsen; Javier Escaned; Bernard J Gersh; Pavel Svitil; Martine Gilard; David Hasdai; Robert Hatala; Felix Mahfoud; Josep Masip; Claudio Muneretto; Marco Valgimigli; Stephan Achenbach; Jeroen J Bax
Journal:  Eur Heart J       Date:  2020-01-14       Impact factor: 29.983

6.  Adenosine stress myocardial contrast echocardiography for the detection of coronary artery disease: a comparison with coronary angiography and cardiac magnetic resonance.

Authors:  J Ranjit Arnold; Theodoros D Karamitsos; Tammy J Pegg; Jane M Francis; Robert Olszewski; Nick Searle; Roxy Senior; Stefan Neubauer; Harald Becher; Joseph B Selvanayagam
Journal:  JACC Cardiovasc Imaging       Date:  2010-09

7.  Prognostic implications of stress echocardiography and impact on patient outcomes: an effective gatekeeper for coronary angiography and revascularization.

Authors:  Siu-Sun Yao; Sripal Bangalore; Farooq A Chaudhry
Journal:  J Am Soc Echocardiogr       Date:  2010-08       Impact factor: 5.251

8.  Prognostic value of stress cardiovascular magnetic resonance in asymptomatic patients with known coronary artery disease.

Authors:  Théo Pezel; Thomas Hovasse; Marine Kinnel; Thierry Unterseeh; Stéphane Champagne; Solenn Toupin; Philippe Garot; Francesca Sanguineti; Jérôme Garot
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-08       Impact factor: 5.364

9.  Vasodilator Myocardial Perfusion Cardiac Magnetic Resonance Imaging Is Superior to Dobutamine Stress Echocardiography in the Detection of Relevant Coronary Artery Stenosis: A Systematic Review and Meta-Analysis on Their Diagnostic Accuracy.

Authors:  Sebastian M Haberkorn; Sandra I Haberkorn; Florian Bönner; Malte Kelm; Gareth Hopkin; Steffen E Petersen
Journal:  Front Cardiovasc Med       Date:  2021-03-12

10.  Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain.

Authors:  Raymond Y Kwong; Yin Ge; Kevin Steel; Scott Bingham; Shuaib Abdullah; Kana Fujikura; Wei Wang; Ankur Pandya; Yi-Yun Chen; J Ronald Mikolich; Sebastian Boland; Andrew E Arai; W Patricia Bandettini; Sujata M Shanbhag; Amit R Patel; Akhil Narang; Afshin Farzaneh-Far; Benjamin Romer; John F Heitner; Jean Y Ho; Jaspal Singh; Chetan Shenoy; Andrew Hughes; Steve W Leung; Meera Marji; Jorge A Gonzalez; Sandeep Mehta; Dipan J Shah; Dany Debs; Subha V Raman; Avirup Guha; Victor A Ferrari; Jeanette Schulz-Menger; Rory Hachamovitch; Matthias Stuber; Orlando P Simonetti
Journal:  J Am Coll Cardiol       Date:  2019-10-08       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.